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Background: With a steady increase in the area cultivated with genetically modified (GM) crops, the impacts of GM
crop cultivation are coming under closer scrutiny around the world. The impacts on humans usually refer to
possible risks to health occurring as a result of the GM food consumption. Other concerns, such as the claims of
human health benefits arising from the cultivation of GM crops via reduced use of pesticides could be considered,
if at all, under economic impacts of the technology. Similarly, other human health impacts could occur as a result
of a modification of the amount of pesticides residues found in underground water, which could be considered
under environmental impacts.
Yet many GM crops are not consumed on-farm, either because they require processing before becoming edible
(such as soya bean, cottonseed and oilseed) or because the entire harvest is sold to maximise profits. It would be
certainly difficult to demonstrate the importance of GM foods health effects versus the non-food health effects of
GM crop cultivation on farmers. However, the non-food health effects, although apparently receiving less attention,
deserve a closer look because of their potential economic and environmental links.
Methods/design: The primary research question is: What are the non-food impacts of GM crop cultivation on
farmers’ health? To address specifically the main research question, the analysis focuses on two related secondary
questions: 1) Does the cultivation of GM crops result in a lower number of pesticide-related poisonings? and 2)
Does the cultivation of GM crops allow for higher financial resources to be used by farmers to improve their and
their family’s health status? Further, the review will also evaluate the extent to which information relevant to the
two secondary questions is freely-available. The abstracts of non-free articles, alongside their bibliographic details,
will be included in a separate table, and if the information supplied would be detailed enough, a summary will be
provided. The search and assessment methodologies (especially the search string, inclusion/exclusion criteria, data
extraction table, data synthesis and presentation) were adapted following problems overcome, and experience
gained, during a scoping search.
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The first GM crop approved for commercialisation was
a GM tomato in 1994 in the USA. In 2012 there were 28
countries growing genetically modified (GM) crops on a
cumulative area of 170 million hectares, making GM
crops the technology with the fastest rate of uptake in
modern agriculture [1]. Individual reports have pointed
towards an array of socio-economic and environmental
advantages derived from such adoption. Apart from an* Correspondence: racovita@icgeb.org
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reproduction in any medium, provided the orincrease in farm income [2], the cultivation of GM crops
has been reported to reduce the environmental impact
of agriculture through: lowering the amount of pesti-
cides applied [3]; decreasing the amount of fossil fuel
consumed and CO2 emitted as ploughing has been re-
duced or avoided [4], and; facilitating conservation till-
age, resulting in better conservation of agricultural soils
[5,6]. Conversely, reports have appeared that indicate
that the cultivation of GM crops results in: an increase
in the use of pesticides [7]; failures to provide signifi-
cantly increased yields [8], and; an increase in allergenic
and toxic effects [9].l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tivation, those pertaining to human health may not be as
easily analysed. Effects on human health can be considered
separately or included in economic or environmental evalua-
tions [4]. Human health effects may occur broadly as a result
of: i) the consumption of GM food [10], ii) the influence of
GM crop cultivation on on-farm pesticide use [11] and iii)
impacts on overall welfare related to changes in on-farm in-
comes. For economic benefits, both pecuniary and non-
pecuniary effects have been described, with health benefits
derived from a reduction in pesticide use amongst the latter
[4]. In other instances, impacts on human health were con-
sidered under broader environmental impacts, within indica-
tors such as the Environmental Impact Quotient (EIQ) [4].
Further, links between agricultural productivity and
health have included health impacts derived from changes
in household income and from impacts on agricultural
production chains generated by the introduction of new
crops [12]. Any modification of household income can
affect patterns of spending within the household, includ-
ing the money available for buying more and/or better
food, paying for medical expenses, and saving [12]. The
introduction of a new crop can bring changes on con-
sumption patterns of other agricultural commodities, on
agricultural practices (e.g. time assigned to on-farm work
can interfere with other activities, or an intensification of
agriculture practices with heavy use of pesticides and ferti-
lisers which in turn can increase the number of accidents
and toxicity from pesticides), and markets (availability of
better/worse products than before) [12].
Due to this multitude of uncoordinated sources of im-
pacts of GM crop cultivation on human health, it is diffi-
cult to obtain a comprehensive overview. In addition,
when addressing human health impacts of GM crops, the
focus is usually on effects resulting from the consumption
of GMOs and GMO-derived agricultural products. The
non-food effects on human health are usually ignored. At
a first look, this might indicate the need for a systematic
mapping for the effects of non-food GM crop cultivation.
However, due to the controversy surrounding GM crops,
the objectivity of articles analysing the impacts of GM
crop cultivation is often questioned. For all the reasons
presented above, the systematic review (SR) was chosen
therefore as the most appropriate methodology to guide
the evaluation of the existing evidence of GM crop non-
food effects on human health and/or to point to a gap in
knowledge, if that should be the case.
The proposed systematic review will review the impacts
of the GM crop cultivation derived from the changes in on-
farm pesticide usage and welfare and the resulting effects
on health (Figure 1). Farmers, as the primary beneficiaries
of GM crop technology to date, represent the population
chosen for this study. Farmers are understood as farm
owners, farm labourers and agricultural contractors indeveloping and developed countries. Although GM crops
have recently come under scrutiny for their role in food
and nutritional security for consumers, comprehensive re-
views of the non-food impacts of GM crop cultivation on
producers’ health are difficult to find. As the focus of the
present systematic review will concern non-food impacts on
GM crop producers rather than on consumers, this review
will not investigate the main health criteria evaluated during
the safety assessments of GM foods, such as toxicity, aller-
genicity, specific nutritional components and nutritional ef-
fects associated with genetic modification, the stability of
the inserted gene, or any unintended effects resulting from
the gene insertion [10]. Further, the contribution of GM
crop cultivation to the lowering of greenhouse gas emis-
sions, sometimes considered as an indirect health effect [4],
as well as health effects determined by possible pesticide
contamination of underground water and improved sanita-
tion will also not be considered during this review.
Objectives
The primary research question is: What are the non-food
impacts of GM crop cultivation on farmers’ health? To ad-
dress the main research question, the analysis focuses on
two related secondary questions: 1) Does the cultivation of
GM crops result in a lower amount of pesticides usage,
leading further to a lower number of pesticide-related poi-
sonings? and 2) Does the cultivation of GM crops allow for
higher financial resources to be used by farmers to improve
their and their family’s health status? “Farmers” are to be
understood as farm owners, labourers, and agricultural
contractors. Both secondary questions look at final out-
comes (number of pesticide-related poisonings and health
related expenditures) through a well-established pathway,
through the presence of intermediary outcomes (amount of
pesticides usage and income derived from GM crop cultiva-
tion). The main concepts to be addressed in this systematic
review (“PE/ICO”; P - Population, E – Exposure/Interven-
tion, C – Comparator, O - Outcome) [13-15] are formu-
lated in Table 1. The review will analyse quantitative
articles estimating the extent of non-food health im-




The following combination of keywords and wildcard
symbols (*, $), linked with Boolean operators ‘AND’ and
‘OR’ will be used to search online databases:
(farmer* OR agric* OR worker OR contractor) AND
((genetic*modif*) OR (genetic*engineer*) OR GE OR
transgene* OR herbicide$tolerant OR insect$resistant OR
biotech* OR BT OR GM OR stacked$trait*) AND (crop*
OR plant* OR flower*) AND (health OR poisoning OR
security OR safety OR welfare OR benefit) AND






















Figure 1 Diagram of human health impacts of GM crop cultivation.
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OR bactericides OR income OR revenue OR gains OR
wage OR profit OR earnings OR livelihood).
The composition of the search string was established as
a result of the searches undertaken within the scoping ex-
ercise (see Additional file 1). The structure of the search
string follows the PICO/PECO structure, albeit in a
slightly modified form. For the Intervention/Exposure we
chose the GM crop cultivation. Yet we wanted to make
sure that the search terms referring to the intervention/ex-
posure could capture only GM crops and not GM insects
or animals. As such, we had one parenthesis with syno-
nyms for “GM” and another for “crop”.
For the Comparator, we did not include any separate
string of key words because it is already included in the
Intervention/Exposure section: (crop* OR plant* OR
flower*).
The Outcomes were separated between intermediary:
(pesticides OR insecticides OR herbicides OR fungicides
OR bactericides OR income OR revenue OR gains OR
wage OR profit OR earnings OR livelihood) and final
outcomes: (health OR poisoning OR security OR safety
OR benefit OR welfare OR environment).
The databases will be divided among 3 reviewers so 2
reviewers will search each database. The databases will be
searched within title, topics and full text. As some data-
bases do not accept the full search string, searches will be
adapted to contain combinations of fewer words (for ex-
ample, one term from each group within brackets united
by an ‘AND’ operator). As this will be database-specific,
the short search strings are not specified a priori. Each re-
viewer will have the operational flexibility to perform their
assigned searches using several word combinations, if the
full search string did not recover any hits. The primary
hits retrieved will be analysed by each reviewer at the title
and abstract level, according to the inclusion/exclusioncriteria detailed in the specific section below. Each re-
viewer will register the exact search string used for each
database, along with the results and their analyses.
In cases where web searches and databases display large
numbers of results in the order of relevance (e.g. Google
Scholar) only the first 100 will be checked. When data-
bases that return results of equal relevance (e.g. Web of
Knowledge) will retrieve a high number of hits (in the
order of thousands) a title search will be performed before
an abstract search.
Publication databases
The list was compiled after consulting the Cochrane Hand-
book for Systematic Reviews of Interventions [16], and fur-
ther supplemented with additional databases suggested by
the reviewers. Some databases for “grey literature” i.e. litera-
ture produced on all levels of government, academics, busi-
ness and industry in print and electronic formats, but
which is not controlled by commercial publishers, were also
included. All databases are free for public use or can be-
come so following online registration for a free trial.
General databases
BioMed Central- www.biomedcentral.com/browse/journals/
Database of Promoting Health Effectiveness Reviews
(DoPHER) - http://eppi.ioe.ac.uk/webdatabases/Intro.
aspx?ID = 2
HighWire Press - http://highwire.stanford.edu/
Latin America and the Caribbean (LILACS) - http://
lilacs.bvsalud.org/en/
Medical Literature Analysis and Retrieval System Online
(MEDLINE) - www.nlm.nih.gov/pubs/factsheets/medline.html
Pubget - http://pubget.com
PubMed Central (PMC) - www.pubmedcentral.nih.gov/
Science Direct - www.sciencedirect.com
Web of Knowledge- http://wokinfo.com/
Table 1 Elements of the systematic review questions
Secondary questions Subject Population Exposure/
Intervention
Outcome Comparator Design
Q1: Does the cultivation of GM





Farmers (understood as farm





any type of GM
trait and any








non-GM crops (both traditional
and organic)
Any study comparing the impacts on
human health, before and after
cultivating GM crops on the same farm,
and between cultivation of GM crops
and cultivation of non-GM crops either
on the same farm or between different
farms, but occurring at the same time
Q2: Does the cultivation of GM
crops allow for higher financial
resources to be used by farmers
to improve their and their family
health status?
Same as above Same as above Same as above Intermediary: income
derived from GM crop
cultivation; Final: health
related expenditures
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national development. (This list includes sources from
academia, industry, as well as civil society)
Agricultural Biotechnology Network in Africa (ABNETA)
- http://abneta.org/
African Centre for Biosafety (ACBIO) - www.acbio.org.za
AgBioForum - www.agbioforum.org/
Bibliosafety database - http://bibliosafety.icgeb.org/=




International Food Policy Research Institute (IFPRI) -
www.ifpri.org/
International Service for the Acquisition of Agri-biotech




Google Scholar - http://scholar.google.com
Other
PhD and Masters theses:
ProQuest (Dissertations & Theses, Dissertations &
Theses (PQDT) A&I, Sociology, Sociological Abstracts) -
www.proquest.co.uk/en-UK/
In addition, the cited literature of 5-10 reviews found
through the search process will be searched as well.
Article screening
Study inclusion/exclusion criteria
The following criteria will be applied to each study to
determine its suitability for further inclusion:
Language: English.
Timeline: Published after 1994 - the year when the
first GM crop was commercially cultivated (on-going re-
search not included)
Population: Farmers (understood as farm owners, farm
labourers and agricultural contractors) in developing
countries and developed countries
Exposure/Intervention: GM cultivation: any type of
GM trait and any type of host crop
Comparator: Non-GM crop cultivation (both trad-
itional and organic)
Outcomes: intermediary outcomes (amount of pesti-
cides usage and income derived from GM crop cultiva-
tion) and final outcomes (number of pesticide-related
poisonings and health related expenditures).
Screening process
Lists will be made with articles that have been analysed
by reviewers at title and abstract level and found to cor-
respond to the inclusion/exclusion criteria, and hence tobe included in the next step. A Cohen Kappa test will be
undertaken to verify consistency of assessment between
reviewers, with a threshold of 0.6. A lower result would
indicate that inclusion/exclusion criteria should be clari-
fied. A final list (Tier 1 list) will be compiled for the full-
text screening stage. The articles that will enter the list
will include all articles identified by each reviewer as
qualifying according to the inclusion/exclusion criteria,
regardless if they are in agreement with the second re-
viewer or not. This measure should eliminate the re-
viewer bias and help retain articles, when in doubt about
their relevance, until examined at full text.
The articles on the Tier 1 list will be divided among 3
reviewers who will then undertake a full text analysis with
the inclusion/exclusion criteria. If the Cohen Kappa test
above had a result of over 0.6, then a second reviewer will
randomly check 10% of the abstracts allocated for each re-
viewer. If the Cohen Kappa test had a result below 0.6,
then the articles will be divided among 3 reviewers with
each article checked by 2 reviewers, after which a Cohen
Kappa test will be performed again with the same stipula-
tions as for the previous step.
The result of this analysis (Tier 2) should be a series of
tables: a table for articles not relevant to the criteria, dupli-
cates, and ex-ante studies; a table with reviews; a table
with articles for which full text was not found even after
contacting the authors; and a table of articles that after a
full text analysis are evaluated as qualifying for data
extraction.
Potential effect modifiers and reasons for heterogeneity
Potential effect modifiers and reasons for heterogeneity
have been established following discussions amongst the
reviewers. The modifiers have been categorised into lar-
ger groups, each with several subgroups, as follows:
1. Type of intervention (GM crops):
1.1.Number of crops analysed
1.2.Type of crops
1.3.Type of trait introduced













3.5.Areas cropped to GM/non-GM
Table 2 Template of data extraction table (modified after
scoping exercise)
Revision date:
Name of person filling the form:
Notes:
ID of the form (usually name of the
first author and year of publication):





Type of intervention (GM crops)
• Number of crops analysed
• Type of crops
• Type of trait













• Area cultivated with GM/non-GM
• Use of pesticide protective measures (if relevant)
Institutional context: subsidies, credits,
price control policies, extension services
• Agricultural subsidies
• Agricultural credits
• Price control policies
• Agricultural extension services
Study design
• Methodology employed
• Frequency and period of data collection
• Sample size
Intermediate outcomes
1. Q1: Pesticide usage
2. Q2: Household income
Final outcomes
• Q1: Number of pesticide-associated illnesses
• Q2: Health-related expenditure
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5.2.Frequency and period of data collection
5.3.Sample size
Data extraction
Studies reported in articles selected after full text
screening will undergo data extraction. The data re-
trieved will be recorded on tables of which the tem-
plate is presented in Table 2. The list of included
articles will be divided among 3 reviewers, with 25% of
data extraction tables randomly checked by a second
reviewer.
Study quality assessment
After analysing several sources from the theoretical
literature for SR [13-16], as well as related SR [17,18]
and based on the present potential effect modifiers, a
set of 8 questions requiring dichotomous answers
(yes/no) were developed to assess the quality of the
articles.
1. Did the study include more than one study area
(country/region within a country)?
2. Were the farmers randomly selected?
3. Did the study include data from more than one year?
4. Did the sources of data rely on written records?
5. Were there any measures in place to deal with
attrition?
6. Did the study test differences between GM adopters
and non-adopters?
7. Did the study test if the farmers’ use of pesticides
protective measures was related to the pesticides-
related poisonings?
8. Did the study include confounding variables in the
calculation of farmers’ income?
The overall purpose of the quality assessment is to
show strong causality, both for the intermediary and
final variables. We need to account that not all questions
are relevant for all articles; 7 questions are relevant for
each secondary research question. As such, each Yes an-
swer will receive a score of 1, while a No will receive a
score of 0. An average score will be calculated for each
study. Below 0.28 the study will have a high susceptibil-
ity to bias; between 0.28 and 0.71 will have a medium
susceptibility to bias; and over 0.71 will have a low sus-
ceptibility to bias.
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than one study area; the farmers are randomly selected; in-
clude data from more than one year; the sources of data
rely on written records; contain measures to deal with at-
trition; test differences between GM adopters and non-
adopters; determine that the farmers’ use of pesticides
protective measures is not related to the pesticides-related
poisonings; include confounding variables in the calcula-
tion of farmers’ income.
Data synthesis and presentation
As the scoping exercise study indicated a heterogeneous
set of methodologies and results, a narrative synthesis will
be made of the data i.e. the findings will be summarised
and described, with no meta-analyses undertaken. Studies
found through the scoping exercise show a high degree of
variability in methodologies, crops and contexts employed,
making the data unsuitable for a meta-analysis [16]. Two
tables will be constructed to summarize findings, based on
the existing data extraction tables, one for each secondary
research question. Summary tables will contain the article
ID as given in the data extraction tables, bibliographic ref-
erences, context of intervention (country/region), meth-
odological design, intermediary and final outcomes, as
well as the overall score and the main sources of bias as
reported by the quality assessment. The low and medium
susceptibility to bias articles for each of the research ques-
tions will be analysed separately from the high susceptibil-
ity to bias ones. Descriptive statistics showing the
countries in which research was undertaken, the types of
crops, types of traits, types of pesticides applied, character-
istics of the farms and farmers studied, as well as the insti-
tutional context will also be provided.
Additional file
Additional file 1: Scoping exercise.
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